- Home
- LBRDK vs QGEN Comparison
LBRDK vs QGEN Comparison
Compare LBRDK & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDK
- QGEN
- Stock Information
- Founded
- LBRDK 2014
- QGEN 1986
- Country
- LBRDK United States
- QGEN Netherlands
- Employees
- LBRDK N/A
- QGEN N/A
- Industry
- LBRDK Cable & Other Pay Television Services
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LBRDK Telecommunications
- QGEN Health Care
- Exchange
- LBRDK Nasdaq
- QGEN Nasdaq
- Market Cap
- LBRDK 12.1B
- QGEN 9.9B
- IPO Year
- LBRDK N/A
- QGEN 1996
- Fundamental
- Price
- LBRDK $85.13
- QGEN $39.85
- Analyst Decision
- LBRDK Buy
- QGEN Buy
- Analyst Count
- LBRDK 2
- QGEN 8
- Target Price
- LBRDK $80.00
- QGEN $49.79
- AVG Volume (30 Days)
- LBRDK 849.0K
- QGEN 1.1M
- Earning Date
- LBRDK 05-07-2025
- QGEN 04-28-2025
- Dividend Yield
- LBRDK N/A
- QGEN 3.30%
- EPS Growth
- LBRDK 29.85
- QGEN N/A
- EPS
- LBRDK 6.08
- QGEN 0.37
- Revenue
- LBRDK $1,016,000,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- LBRDK $3.15
- QGEN $5.15
- Revenue Next Year
- LBRDK $1.15
- QGEN $6.49
- P/E Ratio
- LBRDK $14.50
- QGEN $107.16
- Revenue Growth
- LBRDK 3.57
- QGEN 0.66
- 52 Week Low
- LBRDK $46.46
- QGEN $37.63
- 52 Week High
- LBRDK $101.50
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- LBRDK 54.95
- QGEN 49.85
- Support Level
- LBRDK $80.79
- QGEN $39.35
- Resistance Level
- LBRDK $89.15
- QGEN $40.11
- Average True Range (ATR)
- LBRDK 2.45
- QGEN 0.54
- MACD
- LBRDK 0.34
- QGEN 0.18
- Stochastic Oscillator
- LBRDK 64.39
- QGEN 80.88
About LBRDK Liberty Broadband Corporation Class C
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).